ããã³ãã¡RFã§æ¯ç©Žã»ãããè·¡ãæ¹åããçç±ââè«æããŒã¿ã§è§£èª¬
ãæ¯ç©Žããããè·¡ããéãšé»æ°ã§ãªããªãââãããè«æã§èšŒæãããŸãããã
çŸå®¹å»çã®äžçã§çŸåšæã泚ç®ãéããŠããæ²»çã®äžã€ããããã³ãã¡ïŒãã©ã¯ã·ã§ãã«ãã€ã¯ãããŒãã«RFïŒMNRFïŒãã§ãããããè·¡ãéããã£ãæ¯ç©ŽããããŠå 霢ã«ããå°ãããããã¿ã«å¯Ÿãããªãããã»ã©ã®å¹æãçºæ®ããã®ã§ãããããæ¬èšäºã§ã¯ãã€ã¡ãŒãžãå£ã³ãã§ã¯ãªããå®éã®å»åŠè«æã«åºã¥ããæ°å€ãšããŒã¿ã培åºçã«åŒçšããããã³ãã¡ã®å§åçãªçŸè广ã®ã¡ã«ããºã ãšå®æ ã解説ããŸãã
ããã³ãã¡ãšã¯äœãââRFãšãã€ã¯ãããŒããªã³ã°ã®ç©¶æ¥µã®çµã¿åãã
ãããã³ãã¡ãä»ã®æ©åšãšæ±ºå®çã«éãçç±ã¯ãå®ã¯éã®å 端ã«ããã
ããŒããã³ã«ä»£è¡šããããã€ã¯ãããŒããªã³ã°ïŒMNïŒã¯ã極现ã®éã§ç®èã«ç©ççãªåŸ®å°ãªå·ãã€ããåµå·æ²»çã®ããã»ã¹ãå©çšããŠã³ã©ãŒã²ã³ãå¢çãããæ²»çã§ããããããããã³ãã¡ïŒMNRFïŒã¯åãªãéæ²»çã§ã¯ãããŸãããéãçç®å±€ã«å°éããç¬éã«ããã®å 端ããRFïŒé«åšæ³¢ïŒãšãã«ã®ãŒãçŽæ¥ç §å°ããããšããç»æçãªã¡ã«ããºã ãæã£ãŠããŸãã
Hwangãã®ç ç©¶ïŒ2025幎ïŒã§ã¯ãèåãé²è¡ããç®èã«å¯ŸããŠããã€ã¯ãããŒãã«åç¬ïŒMNïŒããšããã€ã¯ãããŒãã«RFïŒMNRFïŒãã®å¹æãæ¯èŒããŸãã[1, 2]ããã®çµæãMNRFã«ããæ²»çã¯ãèåã®å å¶ã§ãããèåç·ç¶èœçްèïŒsenescent fibroblastsïŒãã®æ°ãæžå°ãããã ãã§ãªããæ°ããã³ã©ãŒã²ã³ããšã©ã¹ãã³ãçã¿åºããéèåç·ç¶èœçްèãã®å¢æ®ãä¿ããšããäºéã®å¹æïŒdual effectïŒãæã€ããšãæããã«ãªããŸãã[1]ã
RFã®ç±ãšãã«ã®ãŒãç®èã«äžããå€åã¯åçã§ããçç®ã®å¥¥æ·±ãã«çŽæ¥ç±ãå ããããããšã§ãç±åçž®ã«ãã峿çãªåŒãç· ã广ãšãé·æçãªçµç¹ã®åæ§ç¯ãèµ·ãããŸããHwangãïŒ2025幎ïŒã®çµç¹åŠçåæã«ãããšãMNRFæ²»çãè¡ã£ãåŽã®ç®èã¯ãåãªãéæ²»çïŒMNïŒãè¡ã£ãåŽãšæ¯èŒããŠãçç®å±€ã«ãããã³ã©ãŒã²ã³ãšãšã©ã¹ãã³ã®ã¬ãã«ãæããã«äžæããŠããŸãã[1]ãããã³ãã¡ã¯ãéã«ããç©ççãªåºæ¿ãšãRFã«ããç±ãšãã«ã®ãŒã®çžä¹å¹æã«ãã£ãŠãèã®åå°ããæ ¹æ¬çãªè¥è¿ããããããã®ã§ãã
ããã³ãã¡ãå¹ãçç¶ââè«æããŒã¿ã瀺ãé©ç°ã®æ¹åç
ããã³ãã¡ã¯ã©ã®ãããªèãã©ãã«ã«å¹æãããã®ã§ãããããããã§ã¯ãèšåºè©ŠéšïŒRCTïŒãªã©ã§å®èšŒãããè«æã®å®æ°å€ãçšããŠãå ·äœçãªå¹æã解説ããŸãã
ãããè·¡ïŒèçž®æ§ç¢çïŒAtrophic scarïŒãžã®å¹æ
æ·±ãå¹ãã§ããŸã£ããããè·¡ïŒèçž®æ§ç¢çïŒã¯ãèªå·±æµã®ã¹ãã³ã±ã¢ã§ã¯æ¹åãæ¥µããŠå°é£ã§ããSitohangãã®ã·ã¹ãããã£ãã¯ã¬ãã¥ãŒïŒ2021幎ïŒã«ããã°ããã€ã¯ãããŒããªã³ã°ãMNRFã¯ãèçž®æ§ãããè·¡ã«å¯ŸããŠäžè²«ããŠé«ãæå¹æ§ã瀺ããŠããŸã[3, 4]ããããè·¡ã®éçåºŠãæž¬ããGoodman & Baron質çã»å®éçåé¡ãããECCAã¹ã±ãŒã«ããçšããè€æ°ã®èšåºè©Šéšã«ãããŠãæç¢ºãªæ¹åã確èªãããŠããŸã[5]ã
ç¹ã«ãAnãïŒ2019幎ïŒã®ã©ã³ãã 忝èŒè©Šéšã§ã¯ãæ·±ã0.8ã1.5mmã®ãã©ã¯ã·ã§ãã«ãã€ã¯ãããŒãã«RFãçšããæ²»çã«ããããããè·¡ã®æ»ããããææã«æ¹åããå·è·¡ã®ãµã€ãºãã®ãã®ãçž®å°ããããšãå ±åãããŠããŸã[6]ãRFã®ç±ãããããè·¡ã®åºã§åãåºãŸã£ãç°åžžãªã³ã©ãŒã²ã³ãç Žå£ããæ°ããæ£åžžãªçµç¹ãžã®åæ§ç¯ã匷åã«åŸæŒãããããã§ãã
æ¯ç©Žçž®å°ã»ç®èåæ³æå¶ã®ããŒã¿
éããæ¯ç©Žãéå°ãªç®èåæ³ã«å¯ŸããŠããããã³ãã¡ã¯åšåãçºæ®ããŸããChoãïŒ2012幎ïŒã®ç ç©¶ã«ãããŠãããã©ã¯ã·ã§ãã«ãã€ã¯ãããŒãã«RFæ²»çãé¡ã®å€§ããªæ¯ç©Žã®æ¹åã«æå¹ã§ããããšã瀺ãããŠããŸã[7]ãéã«ããç©ççåºæ¿ãšRFã®ç±ãç®èè ºã«ã¢ãããŒãããéå°ãªç®èåæ³ãæå¶ããããšã§ãæ¯ç©Žã®éããç©ççã«åŒãç· ãã广ãæåŸ ã§ããŸãã
å°ããã»ããã¿ãžã®å¹æïŒã³ã©ãŒã²ã³å¢çã®%ããŒã¿ïŒ
å 霢ã«äŒŽãå°ãããããã¿ã®åå ã¯ãçç®å ã®ã³ã©ãŒã²ã³ãšãšã©ã¹ãã³ã®æžå°ã§ããWamsleyãã®ç ç©¶ïŒ2021幎ïŒã§ã¯ãè¶ é³æ³¢ç»åãçšããéäŸµè¥²çæž¬å®ã«ãããæ²»ç1ã¶æåŸïŒ120æ¥ç®ïŒããçç®ã®å¯åºŠãåçã«äžæããããšã瀺ãããŸãã[8]ãããã«ã3ã¶æåŸïŒ180æ¥ç®ïŒã«ã¯é¡ã®çç®å¯åºŠãããŒã¹ã©ã€ã³ãã101.86%ãå¢å ïŒP<0.001ïŒãã衚ç®å¯åºŠã19.28%å¢å ãããšããé©ç°çãªå®æ°å€ãå ±åãããŠããŸã[8]ãé¡ã®åŒŸåæ§ïŒElasticityïŒã«ã€ããŠããããŒã¹ã©ã€ã³ãã28.2%ã®å¢å ã確èªãããŸãã[9]ã
ãŸããEl-DomyatiãïŒ2015幎ïŒã«ãããã€ã¯ãããŒããªã³ã°ã®çµç¹åŠçå®éè©äŸ¡ã§ã¯ãæ²»ç3ã¶æåŸã«ãããŠãèã®ããªãæ¯ããIåã³ã©ãŒã²ã³ã58.1±5.1%ãã69.9±5.4%ãžïŒP=0.01ïŒãæè»æ§ãä¿ã€IIIåã³ã©ãŒã²ã³ã55.6±4.7%ãã67.8±6.1%ãžïŒP=0.01ïŒãšææã«å¢å ããããšã蚌æãããŠããŸã[10, 11]ãHwangãïŒ2025幎ïŒã®ç ç©¶ã§ããMNRFæ²»ç5ã¶æåŸã®ã·ã¯ïŒR1ïŒèã®ç²ãïŒã®æ°å€ã1.45±0.23ãã1.19±0.14ãžãšçµ±èšçã«ææã«æ¹åïŒp=0.042ïŒããŠããŸã[12]ã
ããŠã³ã¿ã€ã ã®å®æ ââãèµ€ã¿ã¯äœæ¥ç¶ãïŒãã«ããŒã¿ã§çãã
çŸå®¹å»çãåããéãæãæ°ã«ãªãã®ããããŠã³ã¿ã€ã ïŒå埩æéïŒãã§ãããæ¿ããèµ€ã¿ãè «ããäœé±éãç¶ãã®ã§ã¯ïŒããšäžå®ã«ãªãæ¹ãå€ãã§ãããã
HwangãïŒ2025幎ïŒã®èšåºããŒã¿ã§ã¯ãçŽ æææ°ïŒErythema IndexïŒèã®èµ€ã¿ãç€ºãæ°å€ïŒãé·æçã«è¿œè·¡ããŠããŸããæ²»çåã®ããŒã¹ã©ã€ã³ã227.96±76.42ã§ãã£ãã®ã«å¯Ÿããæ²»çåŸ5ã¶æã®æç¹ã§ã¯227.12±66.87ã§ãããçµ±èšçãªææå·®ã¯å šãèŠãããŸããã§ããïŒp=0.538ïŒ[13]ãããã¯ãããã³ãã¡ã«ããèµ€ã¿ã¯ãããŸã§äžæçãªãã®ã§ãããé·æçãªè²çŽ æ²çãèµ€ãé¡ã®åå ã«ã¯ãªããªãããšã匷ãè£ä»ããŠããŸãã
ãŸããSitohangãã®ã¬ãã¥ãŒïŒ2021幎ïŒã§ãããã€ã¯ãããŒããªã³ã°æ²»çåŸã«ã¯äžæçãªè»œãçã¿ãçŽ æãæµ®è «ïŒããã¿ïŒãçããå¯èœæ§ããããã®ã®ãæ·±å»ãªå¯äœçšã¯äžåå ±åãããŠããªããšçµè«ä»ããããŠããŸã[3, 14]ãåºåã¬ãã«ãéã®æ·±ãã«ãã£ãŠããŠã³ã¿ã€ã ã«ã¯å人差ãåºãŸãããäžè¬çã«ã¯æ°æ¥çšåºŠã§ã¡ã€ã¯ã§é ããã¬ãã«ã«èœã¡çããŸããããŠã³ã¿ã€ã ãããã«ççž®ããããã«ã¯ãæ²»ççŽåŸã®åŸ¹åºããä¿æ¹¿ãã玫å€ç·å¯ŸçïŒSPF30以äžã®æ¥çŒãæ¢ãïŒãªã©ã®é©åãªã¢ãã¿ãŒã±ã¢ã極ããŠéèŠã§ã[15, 16]ã
ãè«æããŒã¿æ¯èŒãçç¶å¥ æ©åšéžæã¬ã€ã
ããã³ãã¡ïŒMNRFïŒ
ãããè·¡
â èçž®æ§ç¢çã«é«å¹æ
æ¯ç©Žã»ç®è
â ç®èè ºãžã®çŽæ¥ã¢ãããŒã
ããã¿ã»å°ãã
â çç®å¯åºŠ+101.86%ïŒè«æå€ïŒ
ããŠã³ã¿ã€ã
â³ æ°æ¥ã1é±é
è²çŽ æ²çãªã¹ã¯
äœïŒè«æïŒææå·®ãªãïŒ
ãã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒ
ãããè·¡
â æ·±ãã¯ã¬ãŒã¿ãŒåã«æå¹
æ¯ç©Žã»ç®è
â 广ãã
ããã¿ã»å°ãã
â é«ãã³ã©ãŒã²ã³å¢ç
ããŠã³ã¿ã€ã
à 1ã2é±é以äž
è²çŽ æ²çãªã¹ã¯
é«ïŒPIHãªã¹ã¯ããïŒ
ããŒããã³ïŒMNåç¬ïŒ
ãããè·¡
â 軜ãäžçåºŠã«æå¹
æ¯ç©Žã»ç®è
â³ éå®ç
ããã¿ã»å°ãã
â ã³ã©ãŒã²ã³èªå°ãã
ããŠã³ã¿ã€ã
â 1ã3æ¥çšåºŠ
è²çŽ æ²çãªã¹ã¯
äœ
â» SitohangãïŒ2021幎ïŒHwangãïŒ2025幎ïŒã®ããŒã¿ãããšã«äœæ
ããã³ãã¡ vs ãã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒ vs ããŒããã³ââã©ããèªåã«åããŠãïŒ
ãåããããè·¡æ²»çã§ãããã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒãšããã³ãã¡ã§ã¯å埩æéã倧ããéãã
ãããè·¡æ²»çãæ€èšããéãããã³ãã¡ããã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒïŒCO2ãEr:YAGãªã©ïŒããããŠããŒããã³ïŒéåžžã®ãã€ã¯ãããŒããªã³ã°ïŒã®ã©ããéžã¶ã¹ããè¿·ãã¯ãã§ããè«æããŒã¿ã«åºã¥ãæ¯èŒã¯ä»¥äžã®éãã§ãã
SitohangãïŒ2021幎ïŒã®ã·ã¹ãããã£ãã¯ã¬ãã¥ãŒã§ã¯ãMNïŒãã€ã¯ãããŒããªã³ã°ïŒããŒã¹ã®æ²»çã¯ã1550nm Er:Glassãã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒãEr:YAGã¬ãŒã¶ãŒãããã«ã¯100% TCA CROSSïŒã±ãã«ã«ããŒãªã³ã°ïŒãšæ¯èŒããŠããæå®³äºè±¡ãå°ãªããããŠã³ã¿ã€ã ãçãïŒshorter downtimeïŒãããšãæç¢ºã«å ±åãããŠããŸã[14]ã
ãã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒã¯åŒ·åãªå¹æãæã¡ãŸããã衚ç®ã«åŒ·ãç±æå·ãäžãããããè²çŽ æ²çïŒPIHïŒã®ãªã¹ã¯ãé·ãããŠã³ã¿ã€ã ã課é¡ãšãªããŸããäžæ¹ãããŒããã³ïŒMNïŒã¯æè»œã§ãããç±ãšãã«ã®ãŒãæããªãããåŒãç· ã广ã«ã¯éçããããŸããããã³ãã¡ã¯ãéãç®èã®å¥¥ïŒçç®ïŒã«å ¥ã£ãŠããRFãç §å°ããããã衚ç®ãžã®ãã¡ãŒãžãæå°éã«æãã€ã€ãçç®ã«åŒ·åãªç±ãå±ããããšãã§ããŸããã€ãŸãããã¬ãŒã¶ãŒäžŠã¿ã®é«ã广ããšãããŒããã³ã®ãããªçãããŠã³ã¿ã€ã ãã®"ãããšãåã"ãããæ²»çãšèšããã®ã§ãã
äœååãããšå¹æãåºãïŒââæœè¡åæ°ãšééã®ç®å®
ã1ååããã°å®å šã«æ²»ãã®ãïŒããšããçåã«å¯ŸããŠã¯ãç®èã®åçãµã€ã¯ã«ã®èгç¹ããçããå¿ èŠããããŸããã³ã©ãŒã²ã³ã®åæ§ç¯ïŒãªã¢ããªã³ã°ïŒã¯éåžžã«ãã£ãããšé²è¡ããããã»ã¹ã§ã[17]ã
HwangãïŒ2025幎ïŒã®èšåºãããã³ã«ã§ã¯ãã4é±éã®ééã空ããŠãåèš4åã®é£ç¶ããMNRFæ²»çãã宿œããé«ãèšåºçã»çµç¹åŠçæ¹åãåŸãŠããŸã[18]ããŸããSitohangãã®ã¬ãã¥ãŒã«ãããŠèšåãããŠããSinghãã®ç ç©¶ã§ã¯ããææãªæ¹åãåŸãã«ã¯æäœã§ã4ã6åã®ã»ãã·ã§ã³ãå¿ èŠã§ããããšæšå¥šãããŠããŸãïŒééã¯2ã4é±éïŒ[17]ã
- 1åã§ã广ãæãããïŒïŒ å€ãã®æ£è ã¯ã1ã2åç®ã®æ²»çåŸããèã®ããªæãåç²§ããªã®è¯ãïŒèçã®æ¹åïŒãšãã£ãåæå¹æã宿ããŸãããããããããè·¡ã®å¹ã¿ãæ·±ãã·ã¯ãªã©ã®çç®ã®åæ§ç¯ãå¿ èŠãªçç¶ã«å¯ŸããŠã¯ã1åã ãã§å®äºãããã®ã§ã¯ãããŸããã
- ç¶æçæ³ã®ã¹ã±ãžã¥ãŒã«ïŒ Fabbrociniãã®å ±åã«ãããšãæ°ããã³ã©ãŒã²ã³ã®æ²çã¯ãã£ããé²ããããæé©ãªçµæãç®ã«èŠãããŸã§ã«ã¯æ²»çåŸ8ã12ã¶æãããããšããããŸã[17]ããããã£ãŠãåææ²»çãšããŠ4é±éã«1åã®ããŒã¹ã§4ã6ååããåŸãèã®ç¶æ ãèŠãªããæ°ã¶æã«1åã®ããŒã¹ã§ã¡ã³ããã³ã¹ïŒç¶æçæ³ïŒãè¡ãã®ãæã广çã§ãã
ãç§ã®å Žåã¯ã©ãã ããïŒããšæã£ãã
ç¡æã«ãŠã³ã»ãªã³ã°ãäºçŽãã
ç¡çãªå§èªã¯ããããŸããããæ°è»œã«ã©ããã
ãã®èšäºã®ãŸãšã
- éïŒRFã®çžä¹å¹æïŒ ããã³ãã¡ã¯ç©ççãªéã®åºæ¿ã«å ããŠRFã®ç±ãšãã«ã®ãŒãçç®ã«å±ããããšã§ãèå现èãæžãããã³ã©ãŒã²ã³ããšã©ã¹ãã³ã®çæãé£èºçã«ä¿é²ããŸã[1]ã
- å®èšŒãããå§åçãªæ¹åçïŒ æ²»çã«ãããé¡ã®çç®å¯åºŠã101.86%ãå¢å ïŒWamsleyãïŒ[8]ãããªã©ãèçž®æ§ãããè·¡ãå°ãããããã¿ã«å¯ŸããŠç§åŠçã«èšŒæãããé«ã广ããããŸãã
- çãããŠã³ã¿ã€ã ïŒ çŽ æïŒèµ€ã¿ïŒã¯æ°æ¥ã§æ¶å€±ãããã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒçãšæ¯èŒããŠé·æçãªè²çŽ æ²çã®ãªã¹ã¯ãäœããå®å šæ§ãé«ãããšãRCTã§å®èšŒãããŠããŸã[13, 14]ã
- æšå¥šãããæ²»çã¹ã±ãžã¥ãŒã«ïŒ åçãªæ¹åã宿ããããã«ã¯ã4é±éééã§4ã6åã®æ²»çãç¶ç¶ããããšãè«æã§ãæšå¥šãããŠããŸã[17, 18]ã
ãå°éå»ãžã®ãçžè«ã®ãæ¡å
ã
ããã³ãã¡ã¯ããããè·¡ãæ¯ç©Žãããã¿ã«æ©ãå€ãã®æ¹ã«ãšã£ãŠã人çãå€ããå¯èœæ§ãç§ããçŽ æŽãããæ²»çæ³ã§ããããããæ£è
æ§ã®ãèã®ç¶æ
ïŒãããè·¡ã®çš®é¡ãæ·±ããè質ïŒã«ãã£ãŠãæé©ãªéã®æ·±ããRFã®åºåèšå®ã¯çްããç°ãªããŸãããã®èšäºã§ã玹ä»ããããŒã¿ã«æåŸ
ãæãããæ¹ããŸãã¯èªåã®èã«ããã³ãã¡ãåã£ãŠãããç¥ãããæ¹ã¯ããŸãã¯ãæ°è»œã«å°éã¯ãªããã¯ãŸã§ãçžè«ãã ãããããªãã®ãèã«æé©ãªããŒã©ãŒã¡ã€ãã®æ²»çãã©ã³ããææ¡ããããŸãã
ãã®èšäºãæžãã人
äžæ å®å éåº§é¢ å»åž«
Zetith Beauty Clinic é座é¢ã»å€§éªå¿ææ©é¢ã»çŠå²¡é¢
æ¥æ¬åœå ããã³åœéåŠäŒã§ã®ç ç©¶çºè¡šå®çžŸãæã¡ãZetith Beauty Clinicå šäœã®æè¡æå°ã»æè²ã«ãæºãããè§£ååŠçæ ¹æ ã«åºã¥ãã粟å¯ãªçŸå®¹å»çãå°éãšããäžäººã²ãšãã®éªšæ Œãçµç¹ã«åãããèªç¶ãªä»äžããã远æ±ããŠããã